Celia Cohen, Esq.
Celia Cohen has significant experience in dealing with white collar defense, internal and government investigations, including investigations of whistleblower claims. A former federal prosecutor, white-collar defense lawyer and in-house attorney, Celia has the insight to advise and defend clients using her expertise handling issues relating to fraud, bribery, money laundering, market manipulation, cybersecurity and matters under the False Claims Act, Foreign Corrupt Practices Act and Sarbanes-Oxley Act.
Prior to joining Norton Rose Fulbright, Celia served for more than five years as Assistant General Counsel at J.P.Morgan Chase, where she led internal investigations for J.P.Morgan Chase's Government, Investigations & Regulatory Enforcement Group. In that capacity, she has successfully overseen complex investigations spanning multiple jurisdictions, has led multiple federal and state False Claims Act investigations. She also represented the bank in response to whistleblower matters and inquiries from the Office of the Comptroller, the Federal Reserve, the Securities and Exchange Commission, the Financial Industry Regulatory Authority, state and federal prosecutors as well as various federal and local law enforcement agencies.
As Assistant US Attorney in the Eastern District of New York from 2009-2015, Celia prosecuted some of the most high-profile matters in the office. She tried nine jury trials to verdict, including an al-Qaeda terrorism trial, a major racketeering case involving six murders and a death penalty case involving the murders of two undercover New York City Police detectives. During her tenure, she handled cases involving securities fraud, international wire fraud, terrorism, cybercrime, healthcare fraud and racketeering.
Before entering public service, Celia practiced for a decade at two major international law firms where she represented individuals and corporations in a variety of white collar and civil litigation matters. In that role, she successfully obtained a full acquittal in a healthcare fraud trial in NY state court. She also successfully obtained a dismissal of insider trading charges brought by the SDNY and the SEC.